The SPAC has said it is not focused on a specific sector, but companies with an enterprise value of $500 million to $1.5 billion. Read more.
Related Posts
TenX Keane Closes $66M IPO with Partial Exercise of Underwriter’s Over-Allotment Option
The SPAC is focused on companies in Asia with an enterprise value of $200 million to $600 million, excluding companies located or operating in mainland China, Hong Kong or Macau.
MSD Acquisition Files for $500M IPO
The new SPAC plans to focus on targets in high-growth sectors including technology and media.
Panacea Shareholders Approve $644M Nuvation Bio Merger
Consideration on the transaction consists of approximately $144 million held in Panacea’s trust (assuming no redemptions). Additionally, a group of healthcare investors has committed to participate in concurrent equity financings totaling slightly more than $500 million at $10 per share.
Twelve Seas Investment II Seeks 9-Month Extension
The SPAC raised $300 million in an IPO two years ago with plans to focus on companies outside the United States, primarily in the Pan-Eurasian region.